498

Compound name
Futibatinib
Alt Name
TAS-120
TAS120
Compound Image
Futibatinib.png
SMILES
COC1=CC(=CC(=C1)C#CC2=NN(C3=NC=NC(=C23)N)C4CCN(C4)C(=O)C=C)OC
MW
418.40
Brutto
C22H22N6O3
InChI
InChI=1S/C22H22N6O3/c1-4-19(29)27-8-7-15(12-27)28-22-20(21(23)24-13-25-22)18(26-28)6-5-14-9-16(30-2)11-17(10-14)31-3/h4,9-11,13,15H,1,7-8,12H2,2-3H3,(H2,23,24,25)/t15-/m0/s1
InChI Key
KEIPNCCJPRMIAX-HNNXBMFYSA-N
Approval Jurisdiction
2022 FDA
Approved for clinical use
Cholangiocarcinoma
CAS
1448169-71-8
PubChem CID
71621331
Action
FGFR2
Approved Drug List
1
Commercial Vendor
Taiho Pharma